132 related articles for article (PubMed ID: 3713871)
1. Neurotensin effect on dopamine release and calcium transport in rat striatum: interactions with diphenylalkylamine calcium antagonists.
Battaini F; Govoni S; Di Giovine S; Trabucchi M
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):267-70. PubMed ID: 3713871
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin effect on calcium transport and dopamine release in rat striatum.
Battaini F; Govoni S; Trabucchi M
Regul Pept Suppl; 1985; 4():188-90. PubMed ID: 2414815
[No Abstract] [Full Text] [Related]
3. Neurotensin facilitates dopamine release in vitro from rat striatal slices.
de Quidt ME; Emson PC
Brain Res; 1983 Sep; 274(2):376-80. PubMed ID: 6626967
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of [3H]dopamine uptake by flunarizine.
Devoto P; Pani L; Kuzmin A; De Montis G
Eur J Pharmacol; 1991 Oct; 203(1):67-9. PubMed ID: 1797556
[TBL] [Abstract][Full Text] [Related]
5. Bay K 8644 stimulation of calcium entry and endogenous dopamine release in rat striatal synaptosomes antagonized by nimodipine.
Woodward JJ; Leslie SW
Brain Res; 1986 Apr; 370(2):397-400. PubMed ID: 2423182
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone.
Lapchak PA; Araujo DM; Quirion R; Beaudet A
J Neurochem; 1991 Feb; 56(2):651-7. PubMed ID: 1899109
[TBL] [Abstract][Full Text] [Related]
7. SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.
Brouard A; Heaulme M; Leyris R; Pelaprat D; Gully D; Kitabgi P; Le Fur G; Rostene W
Eur J Pharmacol; 1994 Mar; 253(3):289-91. PubMed ID: 8200423
[TBL] [Abstract][Full Text] [Related]
8. Investigations of the roles of dihydropyridine and omega-conotoxin-sensitive calcium channels in mediating depolarisation-evoked endogenous dopamine release from striatal slices.
Herdon H; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):36-40. PubMed ID: 2552331
[TBL] [Abstract][Full Text] [Related]
9. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain.
Silverstein FS; Buchanan K; Hudson C; Johnston MV
Stroke; 1986; 17(3):477-82. PubMed ID: 3715946
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat.
Koizumi S; Kataoka Y; Niwa M; Kumakura K
Neurosci Lett; 1992 Jan; 134(2):219-22. PubMed ID: 1589148
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat.
Hétier E; Boireau A; Dubédat P; Blanchard JC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):13-7. PubMed ID: 3368012
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices.
Okuma Y; Fukuda Y; Osumi Y
Eur J Pharmacol; 1983 Sep; 93(1-2):27-33. PubMed ID: 6628546
[TBL] [Abstract][Full Text] [Related]
13. Flunarizine potentiates cocaine-induced dopamine release and motor stimulation in rats.
Pani L; Kuzmin A; Stefanini E; Gessa GL; Rossetti ZL
Eur J Pharmacol; 1990 Nov; 190(1-2):223-7. PubMed ID: 2076754
[TBL] [Abstract][Full Text] [Related]
14. Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats.
Kato T; Otsu Y; Furune Y; Yamamoto T
Neurochem Int; 1992 Jul; 21(1):99-107. PubMed ID: 1303146
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis.
Okada M; Wada K; Kiryu K; Kawata Y; Mizuno K; Kondo T; Tasaki H; Kaneko S
Br J Pharmacol; 1998 Mar; 123(5):805-14. PubMed ID: 9535007
[TBL] [Abstract][Full Text] [Related]
16. Effect of neurotensin and its fragments neurotensin-(1-6) and neurotensin-(8-13) on dopamine release from cat striatum.
Markstein R; Emson P
Eur J Pharmacol; 1988 Jul; 152(1-2):147-52. PubMed ID: 3208829
[TBL] [Abstract][Full Text] [Related]
17. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
18. Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736).
Nordström O; Braesch-Andersen S; Bartfai T
Acta Physiol Scand; 1986 Jan; 126(1):115-9. PubMed ID: 3953299
[TBL] [Abstract][Full Text] [Related]
19. Flunarizine, a calcium influx blocker, inhibits TRH-but not potassium-stimulated prolactin secretion.
Merritt JE; Tomlinson S; Brown BL
Acta Endocrinol (Copenh); 1984 Sep; 107(1):31-5. PubMed ID: 6435368
[TBL] [Abstract][Full Text] [Related]
20. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
Töröcsik A; Rakovska A; Görcs T; Vizi ES
Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
